Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary‐progressive and relapsing‐remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases

BACKGROUND: Primary‐progressive multiple sclerosis (PPMS) and relapsing‐remitting multiple sclerosis (RRMS) are two frequent multiple sclerosis (MS) subtypes that involve 10%–15% of patients. PPMS progresses slowly and is diagnosed later in life. Both subtypes are influenced by genetic and environme...

Descripción completa

Detalles Bibliográficos
Autores principales: Prajjwal, Priyadarshi, Marsool, Mohammed Dheyaa Marsool, Asharaf, Shahnaz, Inban, Pugazhendi, Gadam, Srikanth, Yadav, Rukesh, Vora, Neel, Nandwana, Varsha, Marsool, Ali Dheyaa Marsool, Amir, Omniat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337274/
https://www.ncbi.nlm.nih.gov/pubmed/37448727
http://dx.doi.org/10.1002/hsr2.1422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337274/
https://www.ncbi.nlm.nih.gov/pubmed/37448727
http://dx.doi.org/10.1002/hsr2.1422

Ejemplares similares